Histone acetyltransferases (HATs) play a key role in transcription control, cell proliferation and differentiation by modulating chromatin structure; however, little is known about their own regulation. Here we show that expression of the viral oncoprotein SV40 T antigen increases histone acetylation and global cellular HAT activities. In addition, it enhances CREB-binding protein HAT activity and modulates its transcriptional activity. Finally, we show that inhibition of cellular histone deacetylases by trichostatin A increases the SV40 infectivity rate. These ®ndings highlight the importance of histone acetylation in the regulation of the cell cycle by oncoviral proteins.
INTRODUCTION
The packaging of the eukaryotic genome into chromatin provides the means for compaction of the entire genome inside the nucleus and restricts the access of many regulatory proteins required for essential biological processes such as replication, transcription, DNA repair and recombination (1) . To counterbalance the repressive nature of chromatin, several factors are able to destabilise the nucleosome in order to facilitate the interaction of proteins with nucleosomal DNA. Recent studies have identi®ed that there are two types of protein complexes capable of altering chromatin structure. One of them utilises the energy coming from ATP hydrolysis to alter the structure of nucleosomes (2) . The second one includes complexes that covalently modify histones (3, 4) by acetylation, methylation, phosphorylation, ubiquitination, etc.
Acetylation of the N-terminal tails of histones has been known for many years to be a process correlating with transcriptional activation (5, 6) , but the acetylation mechanisms and functions are just beginning to be revealed, thanks to the identi®cation of the nuclear histone acetyltransferases (HATs). CBP/p300 is a coactivator protein (7) , involved in both proliferative and differentiating pathways, which possesses HAT activity (8, 9) . CBP/p300 is ubiquitously expressed and regulates a broad spectrum of biological activities such as differentiation, cell cycle control, apoptosis and tumorigenesis. CBP/p300 is recruited to speci®c promoters through interactions with sequence-speci®c activators, and in turn recruits a second coactivator such as P/CAF (p300/CBPassociated factor) (10) . These activators include CREB (11) , c-Myb (12) , MyoD (13) , E2F1 (14) , p53 (15) and nuclear hormone receptors (16) . All of these interactions are critical for the execution of fundamental biological functions such as cell differentiation, cell proliferation, apoptosis, etc.
The mechanism of the CBP/p300-mediated activation of transcription is not clear, although we know that CBP/p300 contains multiple activation domains, it can contact the basal transcription factors TATA box-binding protein (TBP) and TFIIB (17) , and its HAT domain is capable of activating transcription (18) . Moreover, other coactivators that complex with CBP/p300, such as P/CAF, activator of retinoic acid receptor (ACTR) (19) and steroid receptor coactivator-1 (SRC-1) (20) , themselves contain intrinsic nucleosomal HAT activity.
SV40 large T antigen is a multifunctional viral oncoprotein implicated in a wide range of cellular processes including transcriptional activation and repression, blockade of differentiation, stimulation of the cell cycle and cell transformation (21) . The SV40 virus gains control of the cell through complex interactions between the viral oncoproteins and various intracellular proteins (22) involved in cell control and regulation of transcription, such as p53 (23, 24) , pRb and Rb-related proteins p107 and p130 (25±28), and CBP/p300 (29±32).
T antigen interacts with the p300 unphosphorylated but ubiquitinated form of the protein (30, 31) and with CREBbinding protein (CBP) (30) . In contrast to T antigen, the adenovirus early expression product E1A interacts with both phosphorylated and unphosphorylated forms of p300. Both T antigen and E1A affect transcription levels of the cAMPresponsive promoter that is modulated in vivo by p300 in REV2 cells. CBP/p300 also interacts with E1A protein and abrogates CBP/p300-mediated transcriptional activity (33) . The mechanism by which this repression occurs is not yet clear. It could occur by sequestration of CBP/p300 away from the promoter; alternatively, E1A may displace the CBP/p300-associated factor, which is required for ef®cient activation of transcription. Another possibility (34, 35) it is that E1A inhibits the HAT activity of CBP/p300 and P/CAF. However, another study has shown an activation of CBP HAT activity by E1A (36) .
Since T antigen also interacts with CBP (30) but very little is known about the consequences on CBP activity, we asked whether T antigen is able to modulate the HAT activity of host cells as well as the CBP coactivator. We show that T antigen expression increases global histone acetylation and CBP HAT activity. Moreover, the T antigen can stimulate HAT-mediated CBP transcriptional activity in a Gal4-hsp70 promoter. Finally, we show that inhibition of cellular histone deacetylases (HDACs) increases the SV40 infectivity rate.
MATERIALS AND METHODS

Constructs
pSG5-T antigen plasmid was a gift of Dr J. DeCaprio. pSG5-T antigen DCBP contains a 379 bp deletion. It was made by partial digestion of the pSG5-T antigen plasmid with NsiI restriction endonuclease, posterior digestion of the puri®ed 6.3 kb fragment with PstI restriction endonuclease and religation of the puri®ed 5.9 kb fragment. pCDNA3Gal4-HAT, pCDNA3Gal4-HAT-CBP2 and pCDNA3Gal4(DBD) constructs have been described elsewhere (18) and were kindly provided by Dr T. Kouzarides. The Gal4-hsp70-b-gal reporter was supplied by Dr J. Bernues. The pCMV-DP1 construct has been described elsewhere (14) and was kindly provided by Dr D. Trouche.
Cell culture, transfections and reporter gene assay CV1 and CV1COS cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) with 10% foetal calf serum (FCS) and grown at 37°C, 5% CO 2 . G 1 cell synchronisation was achieved by removal of FCS from the medium (DMEM) for 36 h and collection of cells 8 h after addition of FCS to the medium.
Cells were transfected by a standard calcium phosphate coprecipitation (for b-galactosidase assays) or using a Jet-PEI Kit (GenyCell) (for HAT assays; by using this method,~80% of the cells were transfected, as we determined by¯uorescence after co-transfection with pCDNA3-GFP) with 0.1±2 mg (as indicated) of either expression vector and 2 mg of b-galactosidase reporter plasmid. The cells were washed after 14 h and harvested 36 h after transfection. After that, they were washed once in phosphate-buffered saline (PBS). For b-galactosidase assay, cells were lysed in 150 ml of b-galactosidase lysis buffer (Promega) for 20 min at room temperature. Supernatants were clari®ed by centrifugation (2 min, 12 000 g) and 30 ml were mixed with 270 ml of b-galactosidase assay solution (Promega) and analysed at OD 420 .
Cell extract preparation, histone extraction and estimation of the protein content Histones were extracted by overnight treatment of whole cells with 0.25 M HCl at 4°C under rotation. After centrifugation at 12 000 g for 10 min at 4°C, histones were precipitated by cold acetone and resuspended in SDS-protein loading buffer. Total cell extracts were prepared as follows: cells were lysed in 1 ml of buffer A (50 mM Tris±HCl, pH 8, 150 mM NaCl, 0.5% NP-40, 10 mg/ml of aprotinin and leupeptin, 1 mM phenylmethylsulfonyl¯uoride, 50 mM NaF and 10 mM Na 2 -b-glycerophosphate) by keeping the cells on ice for 20 min, and cell debris was removed by centrifugation at 12 000 g for 10 min at 4°C. Estimation of the protein content was done by using the`Bio-Rad protein Assay reagent' following the the manufacturer's instructions.
Immunoprecipitations and western analysis
Immunoprecipitations and western blot analysis were performed as described elsewhere (37) with modi®cations: 10-cm dishes of CV1 cells and transfected CV1 cells with the indicated amount of each expression vector were harvested 36 h post-transfection. Cells were lysed in 1 ml of buffer A by keeping them on ice for 20 min, debris was removed by centrifugation and the cleared lysate was subjected to immunoprecipitation with 2 mg of CBP antibody for 3 h at 4°C with rotation. A 15 ml aliquot of protein A/protein G±Sepharose beads (a 50:50 mix) was then added and incubated overnight at 4°C under rotation. The immune complexes were pelleted by gentle centrifugation and washed three times with 1 ml of lysis buffer B (20 mM Tris±HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA and 0.5% NP-40). After the ®nal wash, the buffer was aspirated and the antibody beads were either resuspended in loading buffer for SDS±PAGE to be analysed by western blot or used in the HAT assay as described below. Western blotting was performed using standard procedures and visualised using an enhanced chemiluminescence kit (Amersham). The antibodies used were: whole antiserum anti-T antigen (a gift from Dr J. DiCaprio), af®nity-puri®ed anti-CBP, A22 (Santa Cruz Biotechnology) at 1:1000 dilution, af®nity-puri®ed antihemagglutinin (HA; Upstate Biotechnology) at 1:1500 dilution, and whole antiserum anti-acetyl-lysine, antibody 193 (abcam) at 1:100 dilution; this antibody was raised against chemically acetylated human histone H4 and reacts with eacetylated lysines of the four core histones.
HAT and IP-HAT assays
IP-HAT assays were performed as described elsewhere (8, 18) . Basically, extracts from CV1, CV1COS or transfected CV1 cells were made using 500 ml of buffer A. The lysis mixture was incubated on ice for 20 min and cleared by centrifugation at 12 000 g for 10 min at 4°C. A 2 mg aliquot of CBP antibody was used to precipitate the CBP for 3 h at 4°C with rotation, then 15 ml of protein A/protein G±Sepharose beads (a 50:50 mix) were added and incubated overnight at 4°C under rotation. The immune complexes were pelleted by gentle centrifugation and washed three times with 1 ml of buffer B. After the ®nal wash, the buffer was aspirated down to 30 ml and the liquid HAT assay was done as described (8) . Puri®ed chicken erythrocyte histones (Sigma) were use as substrate.
Viral infection
Subcon¯uent CV1 cells were infected with the SV40 virus as described in Su and DePamphilis (38) , and grown for 8±10 days in DMEM with 5% FCS, 0.9% agar and 75, 100 or 150 nM Trichostatin A (TSA). After 8±10 days, they were stained with neutral red and the lysis colonies were counted after 24±48 h.
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Bioinformatics tools
Sequence searches were done using the PSI-BLAST program (39) with default parameters. The multiple sequence alignment for the E1A family was obtained from the Pfam database (40) , with accession number PF02703.
RESULTS
T antigen expression affects cellular histone acetylation
Several independent ®ndings indicate that HATs and HDACs play an important role in cell cycle regulation, suggesting that these enzymes represent likely targets of viral oncoproteins that deregulate the cell cycle.
To test whether global HAT activities are modi®ed by the SV40 regulatory oncoprotein T antigen, we analysed the HAT activity of cells expressing (CV1COS cell line) and not expressing (CV1 cell line) the SV40 T antigen, by an in vitro HAT assay. To that end, total cellular extracts from CV1 and CV1COS were prepared, the total protein amount was adjusted and the extracts were incubated with puri®ed chicken erythrocyte core histones and [ 3 H]acetyl-CoA. The level of histone acetylation was analysed by¯uorography (Fig. 1A ) and quanti®ed in a scintillation counter (Fig. 1B) . The global HAT activity was~2.3 fold (1.9±2.5) higher in T antigenexpressing cells (Fig. 1B) . To con®rm this result, we transfected the T antigen on CV1 cells (80% of the cells were transfected), adjusted the total protein amount in the cell extracts and determined the HAT activity of T antigentransfected and non-transfected cells by liquid HAT assay. The results in Figure 1C show an increased global HAT activity after T antigen expression.
We then aimed at elucidating whether the histones from cells expressing the T antigen were more acetylated than those from non-expressing cells. To this end, histones from both CV1 and CV1COS cells were prepared by acid extraction and their level of acetylation was analysed by western blot using an antibody raised against chemically acetylated human histone H4 which reacts with e-acetylated lysines of the four core histones (abcam, ab 193) (41) . The results in Figure 2 show that the acetylation level of H3, H2A/B and H4 in T antigen-expressing cells (CV1COS) was 5-fold higher than in non-expressing cells (CV1). The acetylation levels of H3 and H2A/B increased more than H4. In particular, the acetylation of H2A/B was as high as H4 acetylation, suggesting that T antigen expression could lead to acetylation of all lysines on H2A/B histones tails in vivo. One reason for such a high H2A/B acetylation could be the fast DNA replication after viral infection. Alternatively, changes in speci®city of cellular HAT after viral infection could account for the observed histone acetylation pattern change. According to that, it would be interesting to check whether the same increase in H2A/B acetylation occurs after infection by other DNA viruses.
These results support that T antigen expression leads to a global increase of HAT activities and histone acetylation level.
T antigen expression affects CBP HAT activity
Given that T antigen binds the third ®nger on the CBP molecule, very close to the HAT domain, and that T antigen expression increases cellular histone acetylation (see above), we next determined whether T antigen expression affects the intrinsic CBP HAT activity. Using an IP-HAT assay approach, CBP from cells expressing or not expressing the T antigen was immunoprecipitated and the HAT activity within the immunopellet assessed. Figure 3A shows that CBP HAT activity in cells expressing T antigen was higher (2.3-fold increase) than in cells lacking the T antigen, especially in cells arrested in G 1 by serum starvation (4.2-fold increase) (Fig. 3B) . Similar amounts of CBP were immunoprecipitated in CV1 and CV1COS cells, as shown in the bottom panels of Figure 3A whole-cell extracts were tested for their ability to acetylate free histones in an in vitro HAT assay (8) . Basically, whole-cell extracts were incubated with puri®ed chicken erythrocyte histones (Sigma) and [ 14 C]acetyl-CoA at 30°C for 30 min. The level of histone acetylation was analysed in an 18% polyacrylamide gel and revealed by¯uorography. (B) To quantify the HAT activity present in CV1 and CV1COS cells, increasing amounts (0.1±10 mg) of CV1 and CV1COS whole-cell extracts were tested for their ability to acetylate free histones in a standard liquid HAT assay. HAT activity is expressed as radioactivity (c.p.m.) associated with 3 H-labelled acetylated core histones. (C) CV1 cells were transfected with 10 mg of pSG5-T antigen and pCDNA3-GFP using a Jet-PEI Kit (GenyCell). Around 80% of the cells were transfected, as determined by¯uorescence. Whole-cell extracts from transfected and non-transfected cells were prepared and used in a liquid HAT assay as in (B). The global HAT activity associated with cells not expressing and expressing T antigen is expressed as radioactivity (c.p.m.) associated with 3 H-labelled acetylated core histones. and B. Western blot analysis revealed no differences in the amount of CBP in the two cell lines (Fig. 3C ). To investigate whether T antigen was directly responsible for this increase in CBP HAT activity in vivo, we introduced a deletion at the C-terminal CBP-binding region on the T antigen (amino acids 401±536) protein which rendered the T antigen unable to bind CBP (Fig. 3D, bottom panel) ; it was named DCBP. We then transfected the wild-type T antigen and the mutant (DCBP) T antigen on CV1 cells (~80% of the cells were transfected), and afterwards we prepared whole-cell extracts, adjusted the total protein amount in transfected and non-transfected cell extracts and determined CBP HAT activity, as previously described. CBP HAT activity showed a reproducible increase after expression of the wild-type T antigen (Fig. 3D) but not of the DCBP T antigen. The expression level of wild-type and DCBP T antigen after transfection on CV1 cells was similar (Fig. 3D,  top panel) . The con®rmation of this result in vitro, by using recombinant puri®ed proteins, was not possible due to the low level of T antigen expression in Escherichia coli.
Altogether, these data suggest that the oncoprotein T antigen modulates cellular HAT activities and in particular CBP HAT activity.
Given that T antigen affects CBP HAT activity, we next tested whether the CBP speci®city for core histones is altered by T antigen expression. To do this, CBP from CV1 and CV1COS cells was immunoprecipitated using antibodies against CBP and HA (as a control antibody) and the HAT activity associated with the immunoprecipitates was analysed by¯uorography (Fig. 4A) , quanti®ed by densitometry in a Molecular Dynamics machine (Fig. 4B, top panel) and normalised relative to the value in CV1 cells (value: 1) (Fig. 4B, bottom panel) . The results in Figure 4A and B con®rm an increased CBP HAT activity on CV1COS cells and show no modi®cation of the CBP speci®city for core histones by the T antigen.
T antigen modulates CBP HAT-mediated activation
Since T antigen affects CBP HAT activity, we aimed at determining whether it also modulates the transcriptional activity mediated by the CBP HAT domain. To avoid interference by other CBP domains, in particular the Cterminus (capable of binding to other proteins such as P/CAF and SRC-1, which also carry their own HAT activity), we separated the CBP HAT and CBP2 (the CBP third ®nger, where the T antigen binds CBP) domains (HAT-CBP2) from the rest of the molecule and fused them with the Gal4 DNAbinding domain (Gal4-HAT-CBP2). Previous results (18) have shown that a region of CBP, encompassing the previously de®ned HAT domain, can stimulate transcription when tethered to a promoter. This stimulatory effect is dependent on HAT activity. The activation capacity of the CBP HAT domain increases by the fusion of the CBP2 domain (which harbours the binding site for a variety of regulatory transcription factors: E2F and c-Fos).
First, we measured the transcriptional activity mediated by the Gal4-HAT-CBP2 domains on the hsp70 promoter, which contain ®ve Gal4-binding sites, by transient transfection, and then we examined whether wild-type and DCBP T antigen affect the transcriptional activity of the Gal4-HAT-CBP2. The results in Figure 5 show that Gal4-HAT-CBP2 activates the hsp70 promoter. We also observed that T antigen ef®ciently stimulated the ability of HAT-CBP2 to activate the hsp70 promoter (Fig. 5A ) in a speci®c manner because, when expressing another protein (DP1), no effect was found (Fig. 5A ). This T antigen coactivation is dependent on CBP binding because the mutant T antigen (DCBP) was also defective in coactivation (Fig. 5B) . To con®rm this result, we have also used a CBP construct that contains only the HAT domain and lacks the CBP2 region (T antigen-binding region) fused to the Gal4 DNA-binding domain (Gal4-HAT). This construct is still able to activate transcription, but is a very weak activator (18) . The results in Figure 5C show that the coactivating effects of T antigen on the transcriptional activity CBP HAT (which has lost the T antigen-binding site) are substantially reduced.
Altogether, the results from the transfection experiments strongly suggest that T antigen binding to CBP (through the CBP2 region) modulates the transcriptional activity mediated by the CBP HAT domain on the hsp70 promoter.
The histone deacetylase inhibitor, TSA, increases the SV40 infectivity rate
Our previous results show that expression of the T antigen leads to an increase in cellular HAT activity, suggesting that T antigen oncoprotein targets HATs and HDACs to deregulate the cell cycle and/or to regulate viral and cellular genes. We next tested whether inhibition of HDAC activity could affect viral growth and infectivity. CV1 cells were infected with SV40 and maintained in the presence or absence of increasing nanomolar concentrations of the potent HDAC inhibitor TSA. After 7±10 days, the cells from duplicate dishes were stained with neutral red and viral lysis plates were counted. In the presence of TSA, the growth rate of SV40 was clearly higher and more lysis plates were generated (3-to 6.5-fold) than in the absence of the HDAC inhibitor (Table 1 ). In addition, after TSA treatment, lysis plates appeared earlier (2±4 days) than in non-treated cells. Similar growth rates were observed with 75±100 nM TSA (above this concentration, cell death started to appear) and at various infection multiplicities (from 4 to 40 p.f.u.). Nucleic
DISCUSSION
The SV40 virus requires cellular proliferation for its own replication. Therefore, one of its regulatory proteins, the T antigen, has evolved to steer cells through the cell cycle. To transform mammalian cells, T antigen needs to interact with three different proteins: one that includes proteins from the Rb-pocket family (resulting in the loss of the ability to suppress growth), p53 and proteins from the CBP/p300 family of coactivators (which facilitate cellular transformation). Here Figure 3 . CBP HAT activity increased after T antigen expression. (A) An equal amount of total protein of CV1 and CV1COS whole-cell extracts was precipitated with anti-CBP antibody and the immunocomplexes were tested for their ability to acetylate free histones in a liquid HAT assay. The presence of T antigen and CBP in the immunoprecipitates in CV1 and CV1COS cells was tested by western blot using anti-T antigen and anti-CBP antibodies, respectively (shown in the bottom part). The data are the average of at least four independent experiments. (B) CV1 and CV1COS cells were serum starved, and the HAT activity analysis was performed as in (A). (C) Increasing amounts of CV1 and CV1COS whole-cell extracts were loaded onto a 7% polyacrylamide gel, and the amounts of CBP in the two cells lines were determined by western blot using anti-CBP antibody. (D) CV1 cells were transfected with 10 mg of pSG5-T antigen (TAg), pSG5-T antigenDCBP (TAgDCBP) antigen and pCDNA3-GFP using a Jet-PEI Kit (GenyCell). Around 80% of the cells were transfected by this method, as con®rmed by¯uorescence. Whole-cell extracts from transfected and non-transfected cells were prepared. An equal amount of total protein was precipitated with anti-CBP antibody and the immunocomplexes tested for their ability to acetylate free histones in a liquid HAT assay (top part) and for the presence of CBP and T antigen by western blot using anti-CBP and anti-T antigen antibodies, respectively (bottom part). The expression levels of TAg and TAgDCBP after transfection were determined by western blot using anti-T antigen antibody (top part). The data are the average of at least three independent transfections.
we have shown that the interaction of T antigen with CBP modulates CBP activities. T antigen expression increases CBP HAT activity, which is higher when the cells have been serum starved. As reported elsewhere, CBP HAT activity is modulated by another viral protein, E1A, although there is considerable controversy in the literature: Ait-Si-Ali et al. (36) have shown that E1A increases CBP HAT activity to a level similar to that obtained in this study, whereas Chakravarti et al. (35) have proposed that CBP and P/CAF HAT activities are inhibited through interaction with E1A, as con®rmed by Hamamori (34) . On the other hand, work from Kouzarides' lab shows that E1A does not alter P/CAF HAT activity in vitro or in vivo (42) . In the case of T antigen, ours is the ®rst report showing a modulation of CBP HAT activity, which supports the hypothesis that cellular HAT activities are a direct target for acetyltransferase regulation by viral oncoproteins.
We have also shown that global histone acetylation status increased after T antigen expression. We believe that this global increase is mainly a consequence of the higher global HAT activity (as shown in Fig. 1 ), or due to the regulation of HAT accessibility to substrate. However, we cannot exclude some indirect effects due to the T antigen-induced transformation process.
What could be the meaning of a global increase in the histone acetylation level? Treissman et al. (43) have shown that H4 hyperacetylation can occur even when transcription is blocked by actinomycin D, suggesting that global histone hyperacetylation can occur when transcription is not active. Transcriptional HATs also play an apparent non-transcriptional role in establishing the total genomic balance of acetylation (44±46). Global acetylation may thus represent a general response of the cells to a stimulus, in this case a viral oncoprotein, which may alter the threshold level to trigger transcription. On the other hand, the general increased histone acetylation level may be due merely to the addition effects of the locally higher acetylation from T antigen-regulated promoters.
E1A and other CBP/p300-binding proteins may interact with the CBP TRAM motif through the FPESDLIL sequence (47) . We searched the SV40 T antigen for this motif by sequence comparison. FPESLIL aligned with a similar peptide in the SV40 T antigen. However, the match falls in an SV40 T antigen region that does not bind CBP. In addition, the BLAST program (48) provides even better identities for the FPESDLIL sequence to proteins that have not been described as CBP partners and show very divergent functions. These two facts suggest that the observed match in the SV40 T antigen is fortuitous. By comparing the whole E1A and SV40 T antigen sequences, we found a certain percentage of identity between two sequence stretches, which do not correspond to the binding site of any of the proteins. Finally, we looked for the pattern FX (D, E) XXXL, identi®ed by E1A and other third ®nger CBP-interacting proteins (p53 and E2F), in the SV40 T antigen, but did not ®nd it. This may be due to the fact that the E1A pattern was derived from a reduced set of protein sequences. When more sequences become available, the pattern may not be as conserved as it seemed from the original data. In the Pfam (39) alignment for the E1A family of proteins, there are changes in all the pattern positions (Fig. 6) , even in those that had been considered ®xed. The SV40 T antigen and E1A could thus have a structurally similar binding surface to CBP, but corresponding to a degenerate sequence pattern. A second option could be that the SV40 T antigen has reporter, 2 mg of Gal4 DNA-binding domain (DBD) or Gal4-HAT-CBP2, and increasing amounts (0.1±2 mg) of pSG5-T antigen, pCDNA3-DP1 or the empty vector. Whole-cell extracts were used in the b-galactosidase assay. The activity derived from the Gal4-hsp70-b-gal reporter plus the pcDNA3-Gal4(DBD) was normalised to 1.0, and the other activities are expressed relative to this. The data are an average of at least six independent transfections. (B) T antigen activates CBP HAT-mediated activation in a CBP binding-dependent manner. CV1 cells were transfected with 2 mg of the Gal4-hsp70-b-gal reporter, 2 mg of Gal4 DBD or Gal4-HAT-CBP2, and increasing amounts (0.1±2 mg) of pSG5-T antigen DCBP or the empty vector. Whole-cell extracts were used in the b-galactosidase assay. The activity derived from the Gal4-hsp70-b-gal reporter plus the pCDNA3-Gal4(DBD) was normalised to 1.0, and the other activities are expressed relative to this. The data are an average of at least four independent transfections. (C) CV1 cells were transfected with 2 mg of the Gal4-hsp70-b-gal reporter, 2 mg of Gal4 DBD or Gal4-HAT, and 0.5 and 2 mg of pSG5-T antigen or the empty vector. The transcriptional activity of the hsp70 promoter was determined as above. The data are an average of at least three independent transfections. Our results point to the key role of the acetylase and deacetylase activities in viral growth promoted by T antigen. They show that a viral oncoprotein may manipulate gene expression by interfering with HAT chromatin-modifying enzymes. These observations highlight the relevance of acetylation/deacetylation pathways in the regulation of cell proliferation and viral infection. CV1 cells were infected with SV40 virus as described in Su and DePamphilis (38) , and they were grown for 8±10 days in DMEM with 5% FCS, 0.9% agar and 0, 75 and 100 nM TSA. After 8±10 days, the cells were stained with neutral red and the lysis colonies were counted after 24±48 h. The numbers of colonies are normalised in non-treated cells to 1. Data are the average lysis plates from duplicate dishes from three independent experiments.
Nucleic Acids Research, 2003, Vol. 31, No. 12 3121
